Neogen (NEOG) Shares Outstanding (2010 - 2026)
Neogen's (NEOG) quarterly Shares Outstanding (Entity) came in at $217.7 million in Q1 2026, little changed year-on-year from $217.0 million in Q1 2025, and little changed quarter-over-quarter from $217.5 million in Q4 2025.
Neogen (NEOG) Shares Outstanding (2010 - 2026) Analysis & Trends
Neogen's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $217.7 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.29% year-over-year to $217.7 million in Q1 2026; TTM through Feb 2026 was $217.7 million, a 0.29% change from a year earlier, with the FY2025 full-year figure at $216.6 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) was little changed at $217.7 million in Q1 2026 per NEOG's latest filing, from $217.5 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $217.7 million in Q1 2026 and bottomed at $107.8 million in Q2 2022.
- The 5-year median for Shares Outstanding (Entity) is $216.6 million (2024), against an average of $197.5 million.
- Across the five-year window, Shares Outstanding (Entity) surged 100.6% in 2023 and changed 0.0% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $216.2 million in 2022, then advanced by 0.17% to $216.5 million in 2023, then gained by 0.2% to $216.9 million in 2024, then advanced by 0.27% to $217.5 million in 2025, then rose by 0.07% to $217.7 million in 2026.
- Per Business Quant, the three latest NEOG Shares Outstanding (Entity) figures stand at $217.7 million (Q1 2026), $217.5 million (Q4 2025), and $217.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 385.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 456.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 867.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 951.57 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 217.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 217.70 Mn |
| Nov 30, 2025 | 217.41 Mn |
| Aug 31, 2025 | 217.22 Mn |
| May 31, 2025 | 216.89 Mn |
| Feb 28, 2025 | 217.03 Mn |
| Nov 30, 2024 | 216.81 Mn |
| Aug 31, 2024 | 216.70 Mn |
| May 31, 2024 | 216.48 Mn |
| Feb 29, 2024 | 216.60 Mn |
| Nov 30, 2023 | 216.41 Mn |
| Aug 31, 2023 | 216.31 Mn |
| May 31, 2023 | 188.88 Mn |
| Feb 28, 2023 | 216.22 Mn |
| Nov 30, 2022 | 216.13 Mn |
| Aug 31, 2022 | 107.84 Mn |
| May 31, 2022 | 107.68 Mn |
| Feb 28, 2022 | 107.82 Mn |
| Nov 30, 2021 | 107.64 Mn |
| Aug 31, 2021 | 107.49 Mn |
| May 31, 2021 | 106.50 Mn |